Epival Syrups 250mg/5ml 120ml

Description

Marketed By:  Abbott Laboratories (Pakistan) Ltd. Therapeutic Segment:  Anti-Epileptic

Generic:  sodium valproate 250mg/5ml

Indication:

Valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures

Product Form: Syrup

Pack Size: 120ml